주 메뉴 바로가기 본문 바로가기 하단 바로가기

Coporate Governance

Accurate and transparent information about our business

Board of Directors

이사회 구성원에 대한 정보 제공
Name Title R&R Experiences Date of appointment
Jin Seok Seo Internal Director
Chairman of BOD
Chairman of BOD KAIST(PH.D.)
(Current) Chairman of BOD, Celltrion inc.
(Former) Vice President of Product Development, Celltrion inc.
(Former) CEO, Celltrion Skincure inc.
(Former) General Executive Director, Celltrion Skincure inc.
(Former) Representative of Biotechnological Laboratory 1, Celltrion inc.
(Former) Head of Product Development Division, Celltrion inc.
(Former) Manager of R&D Unit
2021-03-26
Woo Sung Kee Internal Director
CEO
Member of Independent Director
Management Hanyang University(B.S)
(Current) CEO, Celltrion inc.
(Former) Vice president, Nexolbiotech
(Former) Deputy general manager, DaeWoo Motor Company
2020-03-27
Min Chul Shin Internal Director
Member of Independent Director
Internal Director (Current) Head of Administration Unit 2020-03-27
Hyuk Jae Lee Internal Director
Member of Independent Director
Internal Director (Current) Head of Product Development Unit 2020-03-27
Young Hyeh Ko Independent Director
Member of Audit Committee
Member of Compensation Committee
Member of Independent Director Recommendation Committee
Independent Director (Current) Visiting Professor in Pathology Department, Korea University Guro Hospital
(Current) Department Manager in Pathology Department, Cheju Halla General Hospital
(Former) Professor in Samsung Medical Center, Sungkyunkwan University
(Former) Vice President of The Korean Society of Pathologists
(Former) Visiting Professor in Pathology Department, Hanyang University
2022-03-25
Keun Young Kim Independent Director
Member of Audit Committee
Member of Compensation Committee
Member of Independent Director Recommendation Committee
Independent Director (Current) Co-representative, Incheon Citizens`Coalition for Economic Justice
(Former) Head of Strategic Planning, Songdo Global Complex Development
2020-03-27
Dae Hyun Yoo Independent Director
Member of Audit Committee
Member of Compensation Committee
Head of Independent Director Recommendation Committee
Independent Director (Current) Hanyang University Rheumatoid Hospital Director
(Former) Chief Director of the Board, Korean College of Rheumatology
2020-03-27
Soon Woo Lee Independent Director
Member of Audit Committee
Head of Compensation Committee
Member of Independent Director Recommendation Committee
Independent Director (Current) Chair Professor in Business Management, Halla University
(Former) Chairman, Woori Financial Group
2020-03-27
Jae Sik Lee Independent Director
Head of Audit Committee
Member of Compensation Committee
Member of Independent Director Recommendation Committee
Independent Director (Current) CPA, Adjunct Professor in Business Management, Hanyang University Institute for Future Talents
(Former) Vice President, KPMG Samjung Accounting Corp.
2020-03-27

Board Committees

위원회 설치현황에 대한 정보 제공
Name of Committee Internal Director Independent Director Main Function
Recommendation Committee 3 directors 5 directors Reviewing the qualifications of potetial candidates and progressing nominees to shareholders meeting
Compensation Committee 0 directors 5 directors Establishing compensation plan for executive officers
Audit Committee 0 directors 5 directors Deliberation of auditing of jobs and accounts, and performance of director's duties

ESG Ratings

ESG 평가 등급에 대한 정보 제공
Period ESG Evaluator Integrated Environmental Social Governance
2021 KCGS (Korea Corporate Governance Service) B C B+ B+
2020 KCGS (Korea Corporate Governance Service) B+ B B B+
2019 KCGS (Korea Corporate Governance Service) B+ B B B+
2018 KCGS (Korea Corporate Governance Service) B B B B
2017 KCGS (Korea Corporate Governance Service) B B B B

5-Year Key Dividend Indicators

배당정보 에 대한 정보 제공
Category FY2021 FY2020 FY2019 FY2018 FY2017
Type Cash&Stock div. Stock div. Stock div. Stock div. Stock div.
Par Value(Won) 1,000 1,000 1,000 1,000 1,000
Total Amount of Cash Div.(mKRW) 102,468 - - - -
Total Amount of Stock Div.(mKRW) 2,732 2,676 6,360 2,492 2,442
Cash Div. per share(Won) 750 - - - -
Stock Div. per share(shares) 0.02 0.02 0.05 0.02 0.02
(Consolidated)Net profit(mKRW) 579,465 517,759 301,030 245,755 368,222
(Consolidated)Cash Div. payout ratio(%) 17.68 - - - -
Cash Div. yield(%) 0.37 - - - -
Stock Div. yield(%) 0.25 5.44 4.01 3.09 13.98

Voting Status for Celltrion's 31st general meeting of shareholders

제 31기 정기주주총회 의결권 행사 현황에 대한 정보 제공
Agendas Resolution Result Total shares with voting rights* Rights Voted For(%)
Against, Abstentions(%)
Agenda 1. Approval of Audited Financial Statements(FY2021) Common Approved 136,623,998 78,170,244 77,447,911 (99.1%)
722,333 (0.9%)
Agenda 2. Election of Directors
- Agenda 2-1. Election of Keun Young Kim as an Independent Director Common Approved 136,623,998 78,170,244 69,680,156 (89.1%)
8,490,088 (10.9%)
- Agenda 2-2. Election of Won Seog Kim as an Independent Director Common Approved 69,255,388 (88.6%)
8,914,856 (11.4%)
- Agenda 2-3. Election of Dae Hyun Yoo as an Independent Director Common Approved 69,077,698 (88.4%)
9,092,546 (11.6%)
- Agenda 2-4. Election of Soon Woo Lee as an Independent Director Common Approved 69,753,628 (89.2%)
8,416,616 (10.8%)
- Agenda 2-5. Election of Young Hyeh Ko as an Independent Director Common Approved 73,795,197 (94.4%)
4,375,047 (5.6%)
Agenda 3. Election of an Independent Director to serve as a member of the Audit Committee
- Election of Jae Sik Lee as an Independent Director to serve as a member of the Audit Committee Common Approved 102,922,171 44,468,417 39,377,847 (88.6%)
5,090,570 (11.4%)
Agenda 4. Election of Audit Committee Members
- Agenda 4-1. Election of Audit Committee member Keun Young Kim Common Approved 102,922,171 44,468,417 30,087,748 (67.7%)
14,380,669 (32.3%)
- Agenda 4-2. Election of Audit Committee member Won Seog Kim Common Approved 29,609,822 (66.6%)
14,858,595 (33.4%)
- Agenda 4-3. Election of Audit Committee member Dae Hyun Yoo Common Approved 29,700,322 (66.8%)
14,768,095 (33.2%)
- Agenda 4-4. Election of Audit Committee member Soon Woo Lee Common Approved 30,151,932 (67.8%)
14,316,485 (32.2%)
- Agenda 4-5. Election of Audit Committee member Young Hyeh Ko Common Approved 40,123,377 (90.2%)
4,345,040 (9.8%)
Agenda 5. Approval of Director Remuneration Limit(FY2022) Common Approved 136,623,998 78,170,244 62,757,557 (80.3%)
15,412,687 (19.7%)
Agenda 6. Approval of Stock Option Grant Common Approved 71,996,244 (92.1%)
6,174,000 (7.9%)
* The number of shares on the agenda for the appointment of an audit committee member is excluded the number of shares with limited voting rights